ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Bioporto A/s

Bioporto A/s (0JJM)

3,20
0,00
( 0,00% )
Mis à jour : 01:00:00

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
3,20
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
3,20 Plage de 52 semaines 3,20
Cap du marché
Clôture Veille
3,20
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 075
Actions en circulation
379 670 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-21,56
Bénéfice par action (BPA)
-0,15
Chiffre d'affairess
30,96M
Bénéfice net
-56,33M

À propos de Bioporto A/s

Secteur
Biological Pds,ex Diagnstics
Industrie
Biotechnology Animal & Plant
Site Web
Siège social
Hellerup, Dnk
Fondé
2004
Bioporto A/s est coté dans le secteur Biological Pds,ex Diagnstics de la London Stock Exchange avec le ticker 0JJM. Le dernier cours de clôture d'Bioporto A/s était de kr3,20. Au cours de la dernière année, les actions de Bioporto A/s ont été négociées dans une fourchette de prix de kr 3,20 à kr 3,20.

Bioporto A/s compte actuellement 379 670 000 actions en circulation. La capitalisation boursière d'Bioporto A/s est de kr1,21 milliard. Bioporto A/s a un ratio cours/bénéfice (ratio PE) de -21.56.

0JJM Dernières nouvelles

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 4, 2024Announcement no. 6 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes the...

BioPorto implements changes to the Executive Management.

BioPorto implements changes to the Executive Management.  January 9, 2024 Announcement no. 01 BioPorto implements changes to the Executive Management. COPENHAGEN, DENMARK and BOSTON, MA...

Managers’ transactions

Managers’ transactions June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in company announcement no. 12...

BioPorto A/S announces completion of rights issue; total number of shares and voting rights

BioPorto A/S announces completion of rights issue; total number of shares and voting rights June 23, 2023Announcement no. 12 BioPorto A/S announces completion of rights issue; total number...

BioPorto A/S announces results of rights issue

BioPorto A/S announces results of rights issue June 21, 2023Announcement no. 11 BioPorto A/S announces results of rights issue COPENHAGEN, Denmark and BOSTON, MA, USA, June 21, 2023, (GLOBE...

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 5, 2023Announcement no. 5 Notice convening the Annual General Meeting in BioPorto A/S The Board of Directors hereby convenes...

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING   November 1, 2022 Announcement no. 14 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING In accordance with Article 5 of the Articles of...

Strong Performance of The NGAL Test Drives Revenue Growth

Strong Performance of The NGAL Test Drives Revenue Growth May 11, 2022Announcement no. 11 Strong Performance of The NGAL Test Drives Revenue Growth Revenues totaled DKK 6.5 million in the...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1003.23.23.200DE
4003.23.23.200DE
12003.23.23.210753.2DE
26003.23.23.220273.2DE
52003.23.23.223233.2DE
156003.23.23.221703.2DE
260003.23.23.220973.2DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CADCadogan Energy Solutions Plc
4,00p
(66,67%)
1,73M
PPSProton Motor Power Systems Plc
0,40p
(33,33%)
3,19M
VRSVersarien Plc
0,039p
(27,87%)
256,46M
KZGKazera Global Plc
1,425p
(26,67%)
24,53M
ORCAOrcadian Energy Plc
12,875p
(14,44%)
295,33k
PXCPhoenix Copper Limited
4,00p
(-27,27%)
6,3M
IPXImpax Asset Management Group Plc
249,00p
(-23,97%)
1,32M
MILAMila Resources Plc
0,40p
(-20,00%)
3,59M
RNEPEcofin U.s. Renewables Infrastructure Trust Plc
27,00p
(-17,43%)
21,5k
PMPPortmeirion Group Plc
175,00p
(-14,63%)
43,09k
NTVONativo Resources Plc
0,0024p
(0,00%)
955,45M
TRPTower Resources Plc
0,027p
(1,89%)
377,95M
VRSVersarien Plc
0,039p
(27,87%)
256,46M
ORCPOracle Power Plc
0,031p
(-12,68%)
246,14M
MSMNMosman Oil And Gas Limited
0,0325p
(-2,99%)
158,08M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock